clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00001575 |
P6099 | clinical trial phase | phase I clinical trial | Q5452194 |
phase II clinical trial | Q42824440 | ||
P17 | country | United States of America | Q30 |
P582 | end time | 2013-11-01 | |
P4135 | maximum age | 80 | |
P1050 | medical condition | lymphoma | Q208414 |
P2899 | minimum age | 18 | |
P1132 | number of participants | 87 | |
P4844 | research intervention | calcium oxalate | Q412399 |
pentetic acid | Q416487 | ||
edetic acid | Q408032 | ||
P6153 | research site | National Institutes of Health | Q390551 |
P580 | start time | 1997-04-01 | |
P8363 | study type | interventional study | Q78089383 |